Cytology Reporting System for Lung Cancer from the Japan Lung Cancer Society and the Japanese Society of Clinical Cytology: An Extensive Study Containing More Benign Lesions
Cytology Reporting System for Lung Cancer from the Japan Lung Cancer Society and the Japanese Society of Clinical Cytology: An Extensive Study Containing More Benign Lesions
复制标题
日本肺癌学会和日本临床细胞学会的肺癌细胞学报告系统:包含更多良性病变的广泛研究
DOI:
10.1159/000520426
复制
发表时间:
2021
期刊:
影响因子:
1.8
通讯作者:
Nakatsuka
中科院分区:
文献类型:
--
作者:
Yoshizawa Akihiko;Hiroshima Kenzo;Takenaka Akemi;Haba Reiji;Kawahara Kunimitsu;Minami Yuko;Kakinuma Hirokuni;Shibuki Yasuo;Miyake Shinji;Kajio Kenta;Kiyonaga Kana;Nagatomo Moe;Nishimura Sanako;Mano Masayuki;Matsubayashi Jun;Motoi Noriko;Nagao T.;Nakatsuka
IntroductionThe Japan Lung Cancer Society (JLCS) and the Japanese Society of Clinical Cytology (JSCC) have proposed a new four-tiered cytology reporting system for lung carcinoma (JLCS-JSCC system). Prior to the proposal, the Papanicolaou Society of Cytopathology (PSC) had proposed a revised reporting system (PSC system), which comprises the “neoplastic, benign neoplasm, and low-grade carcinoma” category (NB-LG category), in addition to the 4 categories of the JLCS-JSCC system. This study aimed to evaluate the interobserver agreement of the JLCS-JSCC system with an additional dataset with more benign lesions in comparison with the PSC system.MethodsWe analyzed 167 cytological samples, which included 17 benign lesions, obtained from the respiratory system. Seven observers classified these cases into each category by reviewing one Papanicolaou-stained slide per case according to the JLCS-JSCC system and PSC system.ResultsThe interobserver agreement was moderate in the JLCS-JSCC (k= 0.499) and PSC (k= 0.485) systems. Of the 167 samples, 17 samples were benign lesions: 7 pulmonary hamartomas, 5 sclerosing pneumocytomas, 2 squamous papillomas, one solitary fibrous tumor, one meningioma, and one lymphocytic proliferation. There were diverse sample types as follows: 11 touch smears, 3 brushing smears, 2 aspirations, and one sputum sample. Fourteen samples (82.3%) were categorized into “negative” or “atypical” by more than half of the observers in the JLCS-JSCC system. Conversely, 3 samples were categorized as “suspicious” or “malignant” by more than half of the observers in the JLCS-JSCC system. On the other hand, 11 samples (64.7%) were categorized into the NB-LG category by more than half of the observers in the PSC system.ConclusionsThe concordance rate in the JLCS-JSCC system was slightly higher than that in the PSC system; however, the interobserver agreement was moderate in both the JLCS-JSCC and PSC systems. These results indicate that both the JLCS-JSCC and PSC systems are clinically useful. Therefore, both systems are expected to have clinical applications. It may be important to integrate the 2 systems and construct a universal system that can be used more widely in clinical practice.
DOI:
10.1038/s41379-020-00698-2
发表时间:
2021-04
期刊:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
影响因子:
--
作者:
Ginter PS;Idress R;D'Alfonso TM;Fineberg S;Jaffer S;Sattar AK;Chagpar A;Wilson P;Harigopal M
通讯作者:
Harigopal M
影响因子:
7.5
作者:
S. Allan;C. B. Lawrence;N. J. Rothwell
通讯作者:
N. J. Rothwell
影响因子:
1.3
作者:
Canberk, Sule;Montezuma, Diana;Schmitt, Fernando
通讯作者:
Schmitt, Fernando